BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 13129885)

  • 1. Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome.
    Font RL; Rishi K
    Ophthalmology; 2003 Sep; 110(9):1833-6. PubMed ID: 13129885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
    Rishi K; Font RL
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sebaceous hyperplasia of the lower eyelid].
    Spraul CW; Jakobczyk-Zmija MJ; Lang GK
    Klin Monbl Augenheilkd; 1999 Nov; 215(5):319-20. PubMed ID: 10609249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
    Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
    Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metachronous occurrence of colorectal cancer in a muir-torre syndrome patient presenting with recurrent sebaceous adenoma of the eyelid: case report and updated review of the literature.
    Agiannidis C; Pana ZD; Molyva D; Kalokasidis K; Mixiou M
    J Cutan Med Surg; 2012; 16(6):394-9. PubMed ID: 23149194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muir-Torre syndrome.
    Cohen PR; Kohn SR; Davis DA; Kurzrock R
    Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
    Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
    Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
    Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
    Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases.
    Demirci H; Nelson CC; Shields CL; Eagle RC; Shields JA
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):77-9. PubMed ID: 17237705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sebaceous adenomas in the absence of Muir-Torre syndrome.
    Sia PI; Rajak S; James C; Huilgol S; Selva D
    Can J Ophthalmol; 2016 Oct; 51(5):e152-e153. PubMed ID: 27769341
    [No Abstract]   [Full Text] [Related]  

  • 13. Muir-Torre syndrome: confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions.
    Fiorentino DF; Nguyen JC; Egbert BM; Swetter SM
    J Am Acad Dermatol; 2004 Mar; 50(3):476-8. PubMed ID: 14988697
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Muir-Torre syndrome family.
    Serleth HJ; Kisken WA
    Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sebaceous adenomas of the eyelid and Muir-Torre Syndrome.
    Jagan L; Zoroquiain P; Bravo-Filho V; Logan P; Qutub M; Burnier MN
    Br J Ophthalmol; 2015 Jul; 99(7):909-13. PubMed ID: 25595178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination.
    Yanaba K; Nakagawa H; Takeda Y; Koyama N; Sugano K
    Br J Dermatol; 2008 Jan; 158(1):150-6. PubMed ID: 17941949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
    J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sebaceous adenoma of the eyelid in Muir-Torre syndrome.
    Singh AD; Mudhar HS; Bhola R; Rundle PA; Rennie IG
    Arch Ophthalmol; 2005 Apr; 123(4):562-5. PubMed ID: 15824235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.